Huajin Capital
华金资本
elsewhere's corpus doesn't carry a standalone profile of Huajin Capital — no founding date, team, or fund size is covered — but it does show up repeatedly as an active investor across hard-tech and biotech rounds. Per a Qiming Venture Partners piece from January 2026, it participated as an existing shareholder in Zenitar's nearly RMB 600 million Series C alongside 5Y Capital, Tencent and Qiming itself ; per Unity Ventures, it led Zhongke Haoxin's Pre-B+ round (RISC-V DSP chips) in mid-2025 with Megmeet following . Earlier activity includes co-leading Bivision Pharmaceuticals' round in July 2024 per Gaorong , and prior investments in Nankai Hecheng and Angtuo alongside Hillhouse-affiliated and healthcare funds . The pattern across 2024–2026 coverage is a cross-sector investor — chips, commercial aerospace supply chains, and innovative drugs — though elsewhere cannot speak to its background or scale beyond these deal appearances.
AI-generated — may contain errors, please verify.
Coverage
Dongsheng Fusion Raises $100 Million in New Funding Round, Co-Led by Qiming Venture Partners
J&T Global Express is committed to developing strong magnetic field compact fusion power plant technology using "deuterium-helium-3" as fuel.
New Forces Keep Coming｜5Y News Monthly
The big news from last month.
BlueRun Ventures-backed Zenitar closes nearly RMB 600 million Series C round | BlueRun Family
Build a closed-loop, iterative system spanning "target identification — molecular design — efficacy validation"
5Y News | Zai Ling Bio Completes Nearly RMB 600 Million Series C Financing
The funding will go toward global clinical development, pipeline expansion, and technology platform upgrades.
Qiming Venture Partners co-leads Zenitar's nearly 600 million yuan Series C round
late-stage clinical biotech company
Unity Ventures Angel-Round Portfolio Company "Skywell" Lists on Nasdaq, Seven Portfolio Companies Announce New Funding Rounds | Unity Ventures Summer Chronicle
Thriving and Expanding, Pushing Boundaries Forward
Haawking Technology Closes Pre-B+ Round to Accelerate RISC-V DSP Chip Innovation and Adoption | Unity Ventures Portfolio News
From DSP core to algorithms, fully self-developed; multiple models in mass production and delivery.
Nankai Hecheng Completes 200 Million Yuan Series B Round | BlueRun Ventures Family
Accelerating Toward a Trillion-Yuan Future for the Polypeptide Industry
Rongbao | Embodied intelligence, chips accelerate commercial rollout and R&D; AI transforms creative industries, finance, and more
Several companies made it onto the annual lists by *China Entrepreneur* and *Fortune*.
CoreVision Biopharma Closes Series A to Accelerate Global Clinical Development of Targeted Radiopharmaceuticals
Advancing a BIC/FIC dual-driven pipeline with a global perspective.
Rongbao | Major Acquisition in Innovative Drugs; Laser Chips, Quantum Computing, and Global Payment Platform Secure New Funding
"Every step forward feels like a bloom."
Onto Innovation Completes Over $50 Million Series A Financing to Accelerate Deep Pipeline Expansion in Nucleic Acid Drugs
Focused on drug development based on antisense oligonucleotide technology.
Code Moment | "Singularity Energy" Closes Over RMB 700 Million Series B Round, Source Code Capital Continues to Double Down
JD Energy will continue to contribute its share of strength to the healthy, high-quality development of the energy storage industry and to the realization of China's dual-carbon goals!
Haijieya Completes New Funding Round to Build Integrated Platform for Interventional Oncology Treatment
Providing a comprehensive suite of minimally invasive interventional diagnosis and treatment solutions for oncology.
Gaorong Monthly · December | Gaorong Ventures and Its Frontier Tech / Consumer / Healthcare / Enterprise Service Portfolio Companies Win Multiple Annual Awards
Its technological and innovative capabilities have won recognition.
